Posts

Patenting stem cell therapies in the US: The role and risks of product-by-process claims (Restem v Jadi cell)

Peas and the peculiarities of product-by-process patents (T 1065/23)

Big Data, products & processes: being a German patentee in the era of the Rezeptortyrosinkinase decisions

Hospira v Genentech - revocation of patents confirmed on appeal

More on Product-by-Process claims - what is the law, why is it, and what should it be?

Hurray for judicial sense on product by process claims - Birss triumphs in Hospira v Genentech